Over-expression of ST3Gal-I promotes mammary tumorigenesis. - Wikidata - wikimedia - TriplyDB

Over-expression of ST3Gal-I promotes mammary tumorigenesis.

Over-expression of ST3Gal-I promotes mammary tumorigenesis.

http://www.wikidata.org/entity/Q34107518

about

Crossroads between Bacterial and Mammalian Glycosyltransferases Inhibition of chemokine (C-C motif) receptor 7 sialylation suppresses CCL19-stimulated proliferation, invasion and anti-anoikis Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy Advancement of Sialyltransferase Inhibitors: Therapeutic Challenges and Opportunities MUC1: a multifaceted oncoprotein with a key role in cancer progression.Glycosylation potential of human prostate cancer cell lines.The sweet and sour of serological glycoprotein tumor biomarker quantification.Overexpression of α2,3sialyl T-antigen in breast cancer determined by miniaturized glycosyltransferase assays and confirmed using tissue microarray immunohistochemical analysis.Aberrant glycosylation associated with enzymes as cancer biomarkers.Transmembrane mucins as novel therapeutic targets Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway Prognostic significance of ST3GAL-1 expression in patients with clear cell renal cell carcinoma Loss of Core 1-derived O-Glycans Decreases Breast Cancer Development in Mice Sialyltransferase and Neuraminidase Levels/Ratios and Sialic Acid Levels in Peripheral Blood B Cells Correlate with Measures of Disease Activity in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Pilot Study.Nutrient-deprived cancer cells preferentially use sialic acid to maintain cell surface glycosylation.Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer Overexpression of ST3Gal-I promotes migration and invasion of HCCLM3 in vitro and poor prognosis in human hepatocellular carcinoma.A Genome-Wide Association Study of Cutaneous Squamous Cell Carcinoma among European Descendants.Expression patterns of α2,3-sialyltransferase I and α2,6-sialyltransferase I in human cutaneous epithelial lesions.Nuclear repartitioning of galectin-1 by an extracellular glycan switch regulates mammary morphogenesis Preferential lectin binding of cancer cells upon sialic acid treatment under nutrient deprivation Altered tumor-cell glycosylation promotes metastasis.The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9.Tumour immunomodulation: mucins in resistance to initiation and maturation of immune response against tumours.Therapeutic potential of carbohydrate-based polymeric and nanoparticle systems.Sialic acids: biomarkers in endocrinal cancers.Interactions of mucins with the Tn or Sialyl Tn cancer antigens including MUC1 are due to GalNAc-GalNAc interactions.α2,6-linked sialic acid serves as a high-affinity receptor for cancer oncolytic virotherapy with Newcastle disease virus.'Multicopy multivalent' glycopolymer-stabilized gold nanoparticles as potential synthetic cancer vaccines.Targeted Immunotherapy Designed to Treat MUC1-Expressing Solid Tumour."Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma.Glycosylation Changes in Brain Cancer.Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1.Integration of lncRNA and mRNA Transcriptome Analyses Reveals Genes and Pathways Potentially Involved in Calf Intestinal Growth and Development during the Early Weeks of Life.A One-Step Chemoenzymatic Labeling Strategy for Probing Sialylated Thomsen-Friedenreich Antigen.CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation.Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities.O-linked mucin-type glycosylation in breast cancer Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer

P2860

Q26866347-6823CBD9-6E41-48C6-A10A-E28EC5E18355 Q28539547-D723861E-A53B-4CE4-B15E-17C408B1F43E Q28539595-2AECD0B5-98C1-4152-8D6D-6763103D20CD Q30039640-658AA1F5-C36D-4C4B-98F3-311AF2CEEBF5 Q33880143-E0FBA22E-65E9-4A66-948A-1BD98F1477DB Q34046293-CCFFD1CD-F939-4C58-890D-80A2EE9E7660 Q34580285-BDF34CD3-451F-4999-94FF-483C92878C31 Q35069229-251A2FE4-CCA3-4C92-95BA-69BA486DBB82 Q35206309-C27ECE21-BD72-4083-ADEF-AA486BDA4CF0 Q35632645-D824BB49-976C-4839-8F18-90EF20FF119E Q35742481-81187D9C-81BC-49BE-9C1B-E1126AE9B769 Q35836524-D6488523-CEAB-4EA7-8983-3A58538DA73B Q35953085-0C5456D5-20BC-4E2F-B50C-0F80641F30FA Q35959088-46A6AB2B-F5DD-4064-9715-80797D7A1A4F Q36315969-26706BF1-4405-49CD-B005-5E5459EE0CB7 Q36492855-E9A27C14-F089-49A3-949C-A6ED3AF82423 Q36833947-444975B2-37AA-472E-9644-57C5533F8D83 Q36917793-6C084CA5-A120-4155-A44B-428425C1185C Q36931879-BCCEBB97-31F9-4D96-B105-FDE3575F3ED5 Q37199993-1ACCBF8E-2E4F-4869-A04C-FBA174D89EBA Q37269017-29581046-9CD0-438A-A2E5-EDE34B5546A7 Q37581540-D1989594-CB10-48D7-9D2A-E00B8AFF4DB8 Q37600827-DF303F74-2B4B-48E8-94AE-D6B85C70149B Q38072479-C4084338-4981-4D11-A02A-B948060582E1 Q38199152-3A6175DB-BB5B-405E-9A26-02901205403A Q38380548-3F5A9552-7A07-4B78-ADBC-9C24F9DEA768 Q39696121-3EFE23CA-8D18-422D-93E9-9FDBD9BAC542 Q40131235-7C322C15-237A-4004-90FD-A5292D786743 Q41965469-DFAA543B-F781-492C-8F8D-38464EB190F4 Q42160992-A68FFCAA-E9AE-4013-B55C-65EFD2524435 Q42366169-1CDA790B-A41E-4216-BE75-EC693F9D5B4C Q47691736-F9105E2D-0ED2-4AF8-A2B7-63366F1D319C Q49901112-FFA60C78-A742-4E07-B5E1-7DEC1C274C13 Q50420655-AC3A98B6-B01F-4088-B217-B747D1BDDEAB Q55226110-29363958-8B06-41CD-939A-E32C0172015A Q55382852-CC3D52D6-8AE6-4501-AAB5-96FCE210E6B8 Q55515607-16356B8E-2BDA-49FC-9A34-5922F0824EAC Q57107715-894650D4-4710-4F36-A290-AF96C0087DE5 Q58093819-DF23E9DA-3B51-4758-BA65-302081BF5825

P2860

Over-expression of ST3Gal-I promotes mammary tumorigenesis.

http://www.wikidata.org/entity/Q34107518

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Over-expression of ST3Gal-I promotes mammary tumorigenesis.

@ast

Over-expression of ST3Gal-I promotes mammary tumorigenesis.

@en

Over-expression of ST3Gal-I promotes mammary tumorigenesis.

@nl

type

label

Over-expression of ST3Gal-I promotes mammary tumorigenesis.

@ast

Over-expression of ST3Gal-I promotes mammary tumorigenesis.

@en

Over-expression of ST3Gal-I promotes mammary tumorigenesis.

@nl

prefLabel

Over-expression of ST3Gal-I promotes mammary tumorigenesis.

@ast

Over-expression of ST3Gal-I promotes mammary tumorigenesis.

@en

Over-expression of ST3Gal-I promotes mammary tumorigenesis.

@nl

P1433

Q34107518-5D8EBA1C-54D4-45EC-9DB7-9D0F2A93B5CE

P1476

Q34107518-96B200B7-7957-4E0F-BAA5-E6B73089B17C

P2093

Q34107518-0EF39C19-B57E-4970-A737-6DEA79D0D538

Q34107518-22D0B115-DFAA-496F-A96B-60D443C828DA

Q34107518-5376DB76-0C70-45FE-9B24-FEC518AD42DC

Q34107518-73352C77-C870-4A46-AF4F-898184B85CC1

Q34107518-7A89D563-784E-41F1-8EED-AA922B1D3DBF

Q34107518-8A5CC01B-8308-466C-9590-92766A7231C4

Q34107518-A7111D53-D3CB-43F5-ACD2-1068392E75F9

Q34107518-AB2B1F5D-B5CF-4BFA-BAB5-EA1676216F5A

Q34107518-C74CCC30-FFF7-45E6-96A4-3698B77F816D

Q34107518-D3149523-F1C8-4B8A-B3E4-6669F99F7C10

P2860

Q34107518-0A657638-33AF-4838-9C6F-BC56DF4811C7

Q34107518-14A27BBE-7752-4B07-865D-9A9BF35EFDB9

Q34107518-1FA481DD-3B99-474D-8E12-139FA7C00444

Q34107518-31C056E5-D971-425F-B340-A61BA6F55335

Q34107518-32BA5B83-9C26-42D3-B584-DDF53E5DB31E

Q34107518-358C267D-8C52-48B1-AC4F-404D96804C23

Q34107518-37D2BC54-BE17-4765-8980-591EC345A412

Q34107518-60272C36-B478-4CA1-82D7-4FBFAC6A12C3

Q34107518-67DFBDDE-D280-43E2-B169-378155AEF1A3

Q34107518-696FAA84-2EAC-411D-B87E-38210E1CDA12

P304

Q34107518-D6A0AF45-24C9-4C07-B586-50B236177A2B

P31

Q34107518-11BD0455-7781-4902-B80D-512ED28AFBD8

P356

Q34107518-B4297879-3073-49F1-BB10-20C8B65C8262

P433

Q34107518-56F64FED-095E-4A62-A89A-0ABBC4ECF288

P478

Q34107518-CE64C758-8F2A-4AA6-811A-CF05A15AF4EE

P50

Q34107518-CB49AA0C-F571-45EA-959E-56DE75F2F345

P577

Q34107518-AB3004CA-CD84-44FE-8866-6CFF5CD9E3A2

P5875

Q34107518-88E8100E-BBD6-4DBC-BA3D-8823A266C0C6

P698

Q34107518-0E776279-1B96-4257-BE94-1FF24C0D7D2F

P932

Q34107518-BCA2C044-205B-495E-9490-12564A43091F

P356

P1433

P1476

Over-expression of ST3Gal-I promotes mammary tumorigenesis.

@en

P2093

Anne Dell

http://www.w3.org/2001/XMLSchema#string

Aristotelis Antonopoulos

http://www.w3.org/2001/XMLSchema#string

Gianfranco Picco

http://www.w3.org/2001/XMLSchema#string

Inka Brockhausen

http://www.w3.org/2001/XMLSchema#string

Joy Burchell

http://www.w3.org/2001/XMLSchema#string

Joyce Taylor-Papadimitriou

http://www.w3.org/2001/XMLSchema#string

Richard Beatson

http://www.w3.org/2001/XMLSchema#string

Stuart Haslam

http://www.w3.org/2001/XMLSchema#string

Sylvain Julien

http://www.w3.org/2001/XMLSchema#string

Ulla Mandel

http://www.w3.org/2001/XMLSchema#string

P2860

Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland

Mucins in cancer: protection and control of the cell surface

Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease

The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1.

Glycosylation defining cancer malignancy: new wine in an old bottle

Transgenic Polyoma middle-T mice model premalignant mammary disease.

Sialic acid capping of CD8beta core 1-O-glycans controls thymocyte-major histocompatibility complex class I interaction.

O-linked glycosylation in the mammary gland: changes that occur during malignancy.

Spontaneous adenocarcinoma mouse models for immunotherapy.

The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.

P304

1241-1250

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/GLYCOB/CWQ085

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Sarah E. Pinder

P577

2010-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44660204

http://www.w3.org/2001/XMLSchema#string

P698

20534593

http://www.w3.org/2001/XMLSchema#string

P932

2934706

http://www.w3.org/2001/XMLSchema#string